Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

7.40USD
29 Jul 2016
Change (% chg)

$-0.05 (-0.67%)
Prev Close
$7.45
Open
$7.42
Day's High
$7.62
Day's Low
$7.33
Volume
14,458
Avg. Vol
27,985
52-wk High
$11.28
52-wk Low
$3.93

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.57 December 29 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 4 0.17 0.21 0.07 0.11
Quarter Ending Dec-16 4 0.18 0.21 0.10 0.11
Year Ending Dec-16 6 0.62 0.82 0.20 5.13
Year Ending Dec-17 5 5.96 14.80 0.00 30.35
Earnings (per share)
Quarter Ending Sep-16 6 -0.57 -0.53 -0.61 -0.50
Quarter Ending Dec-16 6 -0.61 -0.53 -0.69 -0.32
Year Ending Dec-16 6 -2.23 -2.10 -2.35 -1.94
Year Ending Dec-17 5 -2.10 -1.47 -2.85 -1.48

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 0.14 0.21 0.06 42.07
Quarter Ending Dec-15 0.15 0.21 0.05 34.29
Quarter Ending Sep-15 0.10 0.21 0.10 101.57
Quarter Ending Jun-15 0.08 0.12 0.05 61.33
Quarter Ending Mar-15 0.05 0.12 0.07 141.04
Earnings (per share)
Quarter Ending Mar-16 -0.58 -0.51 0.07 -12.82
Quarter Ending Dec-15 -0.57 -0.58 0.01 -1.75
Quarter Ending Sep-15 -0.59 -0.53 0.06 -10.43
Quarter Ending Jun-15 -0.46 -0.58 0.12 -25.19
Quarter Ending Mar-15 -0.45 -0.46 0.01 -1.84

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.17 0.17 0.17 0.17 0.11
Quarter Ending Dec-16 0.18 0.18 0.18 0.17 0.11
Year Ending Dec-16 0.62 0.62 0.62 0.62 5.13
Year Ending Dec-17 5.96 5.96 5.96 5.96 30.35
Earnings (per share)
Quarter Ending Sep-16 -0.57 -0.57 -0.57 -0.57 -0.50
Quarter Ending Dec-16 -0.61 -0.61 -0.60 -0.60 -0.32
Year Ending Dec-16 -2.23 -2.23 -2.23 -2.23 -1.94
Year Ending Dec-17 -2.10 -2.10 -2.06 -2.06 -1.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 1 0
Quarter Ending Dec-16 0 0 0 1
Year Ending Dec-16 0 0 1 0
Year Ending Dec-17 0 0 0 1

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.